Isomorphic Labs raises $5B Series C, five years in with no drug yet in human trials
TorturedPoet30 · reddit · 2026-11-17
Isomorphic Labs, founded in 2021 by Demis Hassabis to build on DeepMind's AlphaFold breakthrough, announced a $5 billion Series C co-led by Greenoaks and Sequoia Capital, with Andreessen Horowitz and continued major investment from Alphabet. All existing investors (Thrive, MGX, GV, CapitalG, Temasek, UK Sovereign AI Fund) participated.
Key facts and open questions:
- Follows a $600M round in March 2025 and a $2.1B Series B in May 2026
- The company says its internal oncology and immunology programs show positive preclinical results, but five years in, no drug candidate has been publicly announced as entering human trials
- Hassabis originally targeted end of 2025 for first trials, then shifted to end of 2026; the new release gives no updated date
Related event: Isomorphic Labs Raises $5 Billion to Solve All Disease with AI(6 posts)→
More from Venture
- Grok Bot Content System: Automate Research, Never Judgment — a $10K Side-Biz Play — PrajwalTomar_ · 2026-11-17
- Solo dev open-sources OpsBridge, an agent workbench for investigating blocked invoices — Fit_Fortune953 · 2026-11-17
- Anthropic's funding roadshow reportedly features just a countdown clock, no slides — morqon · 2026-11-17
- Isomorphic Labs raises $5B to accelerate AI-first drug design, says Demis Hassabis — demishassabis · 2026-11-17
- California sues OpenAI over agent incidents; Li Yanhong says AI value lies in apps — 快鲤鱼 · 2026-11-17
- Indie dev's cloud bill for Pearl Chat is so steep he jokes about a poultry farm — weskambale · 2026-11-17